The cancer tissue page shows antibody staining in 20 different cancers. The overall cancer tissue staining statistics shows the fraction of patient samples with strong, moderate, weak or no staining (as described by the color-coding scale in the box to the right), using all the available antibodies to the protein targets encoded by this gene. The assay and annotation is described here.
The cancers can be ordered histologically or alphabetically.
For each cancer, the staining for each available antibody is reported as the fraction of samples with strong, moderate, weak or no staining (as described by the color-coding scale in the box to the right). The lenght of the bar represents the number of patient samples analysed (max=12 patients). By clicking on a cancer tissue, the detailed staining data for that cancer is available, including annotated images.
At the bottom of this page, a summary for the cancer staining for each antibody is given, together with the immunohistochemistry validation score for that antibody.
Most cholangiocarcinomas along with several colorectal, ovarian, cervical and urothelial cancers showed moderate cytoplasmic positivity. Remaining malignant cells were in general weakly stained or negative.
Several colorectal, ovarian, endometrial, head-neck, pancreatic and urinary bladder showed moderate to strong cytoplasmic and/or membranous staining. A majority of breast cancers displayed moderate cytoplasmic staining.
A majority of malignant cells displayed moderate cytoplasmic immunoreactivity. Thyroid cancers and a few cases of colorectal cancers revealed strong positivity. Most skin cancers, malignant lymphomas and gliomas were negative.
Validation
Two (or more) antibodies yielding similar or partly similar staining patterns and there is no available gene/protein characterization data
Two (or more) antibodies yielding similar or partly similar staining patterns and there is no available gene/protein characterization data
Two (or more) antibodies yielding similar or partly similar staining patterns and there is no available gene/protein characterization data
